BackLexaria Bioscience Overview

Lexaria Bioscience Research & Development

Research & Development expenses for LEXX.

Quarterly R&D Expenses

$970834.00
↓ 64.27% YoY

As of May 31, 2026

Annual R&D Expenses (TTM)

$4.00M
↓ 45.39% YoY

Trailing 12 months ending May 31, 2026

Average R&D Expenses (Comparison Companies)

Research & Development History

Research & Development Comparison

Annual Research & Development Growth Rate (%)

Annual Research & Development Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin